Decentralized clinical trials are the future of medical research. They offer in-home clinical services providing convenience and flexibility. Since the onset of the pandemic, more people are looking forward to accessing everything remotely, including healthcare. For clinical trials, there’s an increased technology adoption to facilitate efficient drugs research. This tells you that decentralized Veristat clinical trials are the way to go. Below find the benefits of decentralized clinical trials.
Improved convenience and flexibility
Decentralized clinical trials are patient-centric as you can participate in them from the comfort of your home. As a result, you cut on transport costs in case you live away from the site. Decentralized clinical trials also consider patients interested to participate but are hindered by immobility issues. They can easily hop on the internet and use the appropriate devices to participate in the research. With technology in the picture, many patients can also be monitored and treated without the fear of skipping work. They can, thus, enjoy more family time as virtual clinical trials offer them the much-needed convenience.
Traditional clinical trials would hinder patients from diverse backgrounds to participate. For instance, it would be tricky to recruit patients from faraway places as it would be difficult for them to afford travel expenses. In contrast, decentralized clinical trials accommodate patients from extensive backgrounds as they participate regardless of their location. Thus, it leads to diversifying the results and ensuring the efficacy of the drugs based on every representative. Getting patients from diverse geographical footprints makes it easy to test how the drugs will affect more extensive patient groups.
Allows for data accuracy
Gone are the days when clinical trials depended on bulk paperwork to capture the patients’ data. By adopting digital data collection, decentralized clinical trials can access more data within seconds. These digital tools include telemedicine, wearable devices, eConsent, electronic clinical outcome assessment (eCOA), electronic health (eHealth), and mobile technologies. Since there are no third parties here, data verification isn’t necessary. Therefore, the process becomes quick and efficient as real data is readily available.
Increases patient recruitment and patient retention
Out of the 100% patients recruited in a clinical trial, 30% drop out before it ends. Therefore, clinical researchers have to come up with ways to retain these patients. With decentralized clinical trials, there’s an ease of protocol adherence to both patients and caregivers. By not needing patients to avail themselves physically at the site, decentralized clinics improve patient recruitment. On top of this, it makes the continuation of the research possible by making it easy for patients to participate regardless of their location.
Present opportunities for extended clinical trials
Decentralized trials reduce research costs for both the patients and the caregivers. Since they help cut on investigators’ fees and travel costs, the extra resources can be directed to more clinical trials. Most importantly, you only need internet cost coverage and the availability of specialized devices. So, with decentralized clinical trials, researchers can save tons of resources that would be exhausted in traditional clinical trials. This way, planning other clinical trials is possible.
Decentralized clinical trials help generate huge benefits for both patients and researchers. As such they help increase efficiency and promote accurate research studies. This seems to be a viable solution for continued trial research even beyond the pandemic.